These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 1830582)
41. Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection. van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; Claessens RA; van der Meer JW; Corstens FH Eur J Nucl Med; 1996 Nov; 23(11):1531-5. PubMed ID: 8854854 [TBL] [Abstract][Full Text] [Related]
42. Structural and functional studies on the human interleukin-6 receptor. Binding, cross-linking, internalization, and degradation of interleukin-6 by fibroblasts transfected with human interleukin-6-receptor cDNA. Rose-John S; Hipp E; Lenz D; Legrés LG; Korr H; Hirano T; Kishimoto T; Heinrich PC J Biol Chem; 1991 Feb; 266(6):3841-6. PubMed ID: 1995637 [TBL] [Abstract][Full Text] [Related]
43. Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues. Takao T; Newton RC; De Souza EB Brain Res; 1993 Sep; 623(1):172-6. PubMed ID: 8221088 [TBL] [Abstract][Full Text] [Related]
44. Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. Chin J; Cameron PM; Rupp E; Schmidt JA J Exp Med; 1987 Jan; 165(1):70-86. PubMed ID: 2947968 [TBL] [Abstract][Full Text] [Related]
45. The interleukin-1 receptor antagonist and its delivery by gene transfer. Evans CH; Robbins PD Receptor; 1994; 4(1):9-15. PubMed ID: 8038709 [TBL] [Abstract][Full Text] [Related]
46. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
47. Down-regulation of interleukin 1 (IL 1) receptor expression by IL 1 and fate of internalized 125I-labeled IL 1 beta in a human large granular lymphocyte cell line. Matsushima K; Yodoi J; Tagaya Y; Oppenheim JJ J Immunol; 1986 Nov; 137(10):3183-8. PubMed ID: 2945861 [TBL] [Abstract][Full Text] [Related]
48. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937 [TBL] [Abstract][Full Text] [Related]
49. Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system. Mahmoudi Azar L; Karaman E; Beyaz B; Göktan I; Eyüpoğlu AE; Kizilel S; Erman B; Gül A; Uysal S BMC Biotechnol; 2023 Jun; 23(1):15. PubMed ID: 37340430 [TBL] [Abstract][Full Text] [Related]
50. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350 [TBL] [Abstract][Full Text] [Related]
51. Murine interleukin 1 receptor. Direct identification by ligand blotting and purification to homogeneity of an interleukin 1-binding glycoprotein. Bird TA; Gearing AJ; Saklatvala J J Biol Chem; 1988 Aug; 263(24):12063-9. PubMed ID: 2969895 [TBL] [Abstract][Full Text] [Related]
52. Identification of a biologically functional novel IL-1 beta-specific receptor on adult rat hepatocytes. Kohira T; Matsumoto K; Ichihara A; Nakamura T J Biochem; 1993 Nov; 114(5):658-62. PubMed ID: 8113217 [TBL] [Abstract][Full Text] [Related]
53. Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Rhyne JA; Mizel SB; Taylor RG; Chedid M; McCall CE Clin Immunol Immunopathol; 1988 Sep; 48(3):354-61. PubMed ID: 2969785 [TBL] [Abstract][Full Text] [Related]
54. Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. Giri JG; Newton RC; Horuk R J Biol Chem; 1990 Oct; 265(29):17416-9. PubMed ID: 2145273 [TBL] [Abstract][Full Text] [Related]
55. N51 competes 125I-interleukin (IL)-8 binding to IL-8R beta but not IL-8R alpha. Structure-function analysis using N51/IL-8 chimeric molecules. Heinrich JN; Bravo R J Biol Chem; 1995 Nov; 270(47):28014-7. PubMed ID: 7499284 [TBL] [Abstract][Full Text] [Related]
56. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. Wietzerbin J; Gaudelet C; Aguet M; Falcoff E J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825 [TBL] [Abstract][Full Text] [Related]
57. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Eisenberg SP; Brewer MT; Verderber E; Heimdal P; Brandhuber BJ; Thompson RC Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5232-6. PubMed ID: 1828896 [TBL] [Abstract][Full Text] [Related]
58. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors. Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081 [TBL] [Abstract][Full Text] [Related]
59. Purification and characterization of a novel soluble receptor for interleukin 1. Symons JA; Eastgate JA; Duff GW J Exp Med; 1991 Nov; 174(5):1251-4. PubMed ID: 1834761 [TBL] [Abstract][Full Text] [Related]